CN112877390B - 一种功能性醇溶鲟鱼软骨制剂的制备方法 - Google Patents
一种功能性醇溶鲟鱼软骨制剂的制备方法 Download PDFInfo
- Publication number
- CN112877390B CN112877390B CN202110120691.9A CN202110120691A CN112877390B CN 112877390 B CN112877390 B CN 112877390B CN 202110120691 A CN202110120691 A CN 202110120691A CN 112877390 B CN112877390 B CN 112877390B
- Authority
- CN
- China
- Prior art keywords
- enzymolysis
- soluble
- cartilage
- sturgeon
- mixed solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000845 cartilage Anatomy 0.000 title claims abstract description 158
- 241000881711 Acipenser sturio Species 0.000 title claims abstract description 147
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 98
- 239000000413 hydrolysate Substances 0.000 claims abstract description 49
- 239000000047 product Substances 0.000 claims abstract description 38
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 34
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 13
- 229920005654 Sephadex Polymers 0.000 claims abstract description 12
- 239000012507 Sephadex™ Substances 0.000 claims abstract description 12
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 12
- 239000011259 mixed solution Substances 0.000 claims description 92
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 62
- 239000008367 deionised water Substances 0.000 claims description 44
- 229910021641 deionized water Inorganic materials 0.000 claims description 44
- 239000007787 solid Substances 0.000 claims description 42
- 108090000526 Papain Proteins 0.000 claims description 40
- 239000004365 Protease Substances 0.000 claims description 40
- 229940055729 papain Drugs 0.000 claims description 40
- 235000019834 papain Nutrition 0.000 claims description 40
- 102000004142 Trypsin Human genes 0.000 claims description 34
- 108090000631 Trypsin Proteins 0.000 claims description 34
- 239000000243 solution Substances 0.000 claims description 34
- 239000012588 trypsin Substances 0.000 claims description 34
- 239000003480 eluent Substances 0.000 claims description 30
- 235000019441 ethanol Nutrition 0.000 claims description 30
- 239000006228 supernatant Substances 0.000 claims description 30
- 238000011068 loading method Methods 0.000 claims description 28
- 238000004108 freeze drying Methods 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 22
- 239000002245 particle Substances 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 16
- 238000002390 rotary evaporation Methods 0.000 claims description 16
- 238000000967 suction filtration Methods 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 15
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 14
- 230000001105 regulatory effect Effects 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 229940088598 enzyme Drugs 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 230000031700 light absorption Effects 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 238000000746 purification Methods 0.000 claims description 11
- 238000010828 elution Methods 0.000 claims description 9
- 235000013372 meat Nutrition 0.000 claims description 9
- 229920001184 polypeptide Polymers 0.000 claims description 9
- 210000003195 fascia Anatomy 0.000 claims description 8
- 150000002632 lipids Chemical class 0.000 claims description 8
- 238000012544 monitoring process Methods 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 4
- 230000003301 hydrolyzing effect Effects 0.000 claims description 4
- CAVKXZMMDNOZJU-UHFFFAOYSA-N Gly-Pro-Ala-Gly-Pro Natural products C1CCC(C(O)=O)N1C(=O)CNC(=O)C(C)NC(=O)C1CCCN1C(=O)CN CAVKXZMMDNOZJU-UHFFFAOYSA-N 0.000 claims description 2
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 claims description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 claims description 2
- YTPLVNUZZOBFFC-SCZZXKLOSA-N Val-Gly-Pro Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N1CCC[C@@H]1C(O)=O YTPLVNUZZOBFFC-SCZZXKLOSA-N 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000000415 inactivating effect Effects 0.000 claims 1
- 230000010355 oscillation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 230000005764 inhibitory process Effects 0.000 abstract description 9
- 230000003833 cell viability Effects 0.000 abstract description 8
- 210000002540 macrophage Anatomy 0.000 abstract description 8
- 239000006227 byproduct Substances 0.000 abstract description 7
- 238000000605 extraction Methods 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- 238000011156 evaluation Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 55
- 239000001963 growth medium Substances 0.000 description 36
- 239000002158 endotoxin Substances 0.000 description 19
- 229920006008 lipopolysaccharide Polymers 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 108010087230 Sincalide Proteins 0.000 description 12
- 238000010609 cell counting kit-8 assay Methods 0.000 description 12
- 238000011534 incubation Methods 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 9
- 239000002699 waste material Substances 0.000 description 9
- 230000009471 action Effects 0.000 description 6
- 238000007605 air drying Methods 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 241000252335 Acipenser Species 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000007731 hot pressing Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 210000004896 polypeptide structure Anatomy 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Marine Sciences & Fisheries (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110120691.9A CN112877390B (zh) | 2021-01-28 | 2021-01-28 | 一种功能性醇溶鲟鱼软骨制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110120691.9A CN112877390B (zh) | 2021-01-28 | 2021-01-28 | 一种功能性醇溶鲟鱼软骨制剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112877390A CN112877390A (zh) | 2021-06-01 |
CN112877390B true CN112877390B (zh) | 2024-04-19 |
Family
ID=76053648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110120691.9A Active CN112877390B (zh) | 2021-01-28 | 2021-01-28 | 一种功能性醇溶鲟鱼软骨制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112877390B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114403455B (zh) * | 2022-01-10 | 2023-06-27 | 大连工业大学 | 一种具有免疫调节活性的鳕鱼肽及其应用 |
CN116999379A (zh) * | 2023-08-14 | 2023-11-07 | 深圳市仙迪化妆品股份有限公司 | 一种鲟鱼子提取物及其制备方法与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107759685A (zh) * | 2017-10-26 | 2018-03-06 | 浙江海洋大学 | 一种鲟鱼鱼骨明胶铁螯合肽及其制备方法 |
CN111269290A (zh) * | 2020-02-28 | 2020-06-12 | 江苏大学 | 一种鲟鱼抗炎肽的制备方法 |
-
2021
- 2021-01-28 CN CN202110120691.9A patent/CN112877390B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107759685A (zh) * | 2017-10-26 | 2018-03-06 | 浙江海洋大学 | 一种鲟鱼鱼骨明胶铁螯合肽及其制备方法 |
CN111269290A (zh) * | 2020-02-28 | 2020-06-12 | 江苏大学 | 一种鲟鱼抗炎肽的制备方法 |
Non-Patent Citations (1)
Title |
---|
醇溶性鲟鱼软骨肽的分离纯化及其体外抗炎活性研究;储倩等;中国食品科学技术学会第十七届年会摘要集;摘要 * |
Also Published As
Publication number | Publication date |
---|---|
CN112877390A (zh) | 2021-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112877390B (zh) | 一种功能性醇溶鲟鱼软骨制剂的制备方法 | |
CN106632605B (zh) | 利用金枪鱼下脚料制备的具有肝损伤修复作用的活性肽 | |
CN108715600B (zh) | 一种促进肠黏膜上皮细胞增殖和迁移的寡肽及其制备方法和应用 | |
CN103882083B (zh) | 一种抗氧化胶原肽的制备方法 | |
CN111269290B (zh) | 一种鲟鱼抗炎肽的制备方法 | |
CN104610430B (zh) | 利用灵芝蛋白制备的抗氧化多肽及其制备方法 | |
Tian et al. | Isolation and purification of antioxidant and ACE‐inhibitory peptides from yak (Bos grunniens) skin | |
CN106560518B (zh) | 一种绿侧花海葵抗***癌寡肽的制备方法 | |
CN115093456A (zh) | 一种具有抗氧化活性的杏仁多肽及其提取方法、应用 | |
CN107177650B (zh) | 一种北太平洋鱿鱼缠卵腺抗氧化酶解寡肽的制备方法 | |
CN110183516B (zh) | 一种降血压银杏果蛋白肽的制备方法 | |
CN110407917B (zh) | 一种促进乳腺酪蛋白合成的章鱼寡肽及其制备方法与应用 | |
CN110105430B (zh) | 一种具有血管紧张素转化酶抑制活性的银杏果蛋白肽及其制备方法 | |
CN108396047A (zh) | 一种小公鱼免疫调节肽的制备方法 | |
CN110194786B (zh) | 一种具有ace抑制活性的银杏果蛋白肽及其制备方法 | |
CN107173815B (zh) | 一种北太平洋鱿鱼缠卵腺抗氧化酶解寡肽的用途 | |
CN116751247A (zh) | 具保肝护肝功效的金枪鱼心脏动脉球抗氧化肽及制备方法和应用 | |
CN113480608B (zh) | 一种可缓解酒精性肝损伤的干腌火腿源多肽及其制备方法 | |
CN110655553B (zh) | 一种芝麻来源的ace抑制肽、制备方法及其在制备降血压药物方面的应用 | |
CN111763243B (zh) | 小公鱼免疫活性肽及其制备方法和用途 | |
CN106084000B (zh) | 一种单环刺螠内脏蛋白源锌螯合肽 | |
CN115057916A (zh) | 一种马氏珠母贝肉抗氧化多肽及其制备方法与应用 | |
CN114539387A (zh) | 一种海洋源抗冻肽制备物及其制备方法与应用 | |
CN106086129A (zh) | 一种单环刺螠内脏蛋白源锌螯合肽的制备方法 | |
CN107176973B (zh) | 一种北太平洋鱿鱼缠卵腺抗氧化酶解寡肽 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240313 Address after: 1003, Building A, Zhiyun Industrial Park, No. 13 Huaxing Road, Henglang Community, Dalang Street, Longhua District, Shenzhen City, Guangdong Province, 518000 Applicant after: Shenzhen Wanzhida Technology Transfer Center Co.,Ltd. Country or region after: China Address before: Zhenjiang City, Jiangsu Province, 212013 Jingkou District Road No. 301 Applicant before: JIANGSU University Country or region before: China |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240318 Address after: East Floor 1, Building C4, Biological Innovation Park, No. 666, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province 430000 Applicant after: Hubei Chang'e Biological Co.,Ltd. Country or region after: China Address before: 1003, Building A, Zhiyun Industrial Park, No. 13 Huaxing Road, Henglang Community, Dalang Street, Longhua District, Shenzhen City, Guangdong Province, 518000 Applicant before: Shenzhen Wanzhida Technology Transfer Center Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |